As part of the National Resident Matching Program, fourth-year medical students at Mayo Clinic Alix School of Medicine and ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Charlotte’s first medical school and the Pearl Innovation District are taking shape. Atrium Health’s med school, innovation ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for ...

This came after Zydus Lifesciences presented a bioequivalence study report ... She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology ...

The discussions emphasised the evolving landscape of acute liver failure, sepsis in chronic liver disease, and post-transplant critical care The Tribune, now published from Chandigarh, started ...

Zydus Lifesciences has launched VaxiFlu-4, India’s first quadrivalent flu vaccine to offer better protection against influenza A and B strains. Experts stress the importance of vaccination and ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against a new strain of influenza virus. The company is introducing the country’s first flu protection quadrivalent ...

Zydus Lifesciences on Wednesday (February 26 ... and people with immunosuppressive and chronic medical conditions. According to the World Health Organisation, seasonal influenza results in ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...

Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced research and development efforts, Zydus Lifesciences Chairman Pankaj R Patel said on Friday.